Naftilux (Naftidrofuryl Oxalate)

Naftidrofuryl oxalate, the active ingredient in Naftilux, is a peripheral vasodilator presented as an oral tablet for oral use. It is used to improve blood flow in patients with peripheral vascular conditions and related symptoms. GNH USA supplies Naftilux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naftilux is indicated for disorders of peripheral circulation and related ischemic conditions. - Peripheral arterial disease: enhances limb perfusion and reduces walking discomfort. - Intermittent claudication: increases exercise tolerance and delays onset of pain. - Cerebrovascular insufficiency: supports cerebral microcirculation to mitigate transient ischemic episodes. - Angina pectoris: improves myocardial oxygen delivery, helping to relieve chest pain.

Adverse reactions may occur with Naftilux use.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness, especially on standing. - Flushing: temporary redness of skin. - Gastrointestinal discomfort: abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Thrombocytopenia: unusually low platelet count. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, consider the following precautions. - Cardiovascular assessment: evaluate baseline blood pressure and heart function. - Monitor for hypotension: advise patients to rise slowly from sitting or lying positions. - Hepatic impairment: use with caution in patients with liver disease. - Hypersensitivity: avoid in individuals with known allergy to Naftidrofuryl or related compounds. - Concomitant antiplatelet agents: assess bleeding risk when combined with other platelet inhibitors. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Naftilux may interact with other medicines; awareness of interaction severity is important.

Major Interactions (Avoid): - Potent vasodilators (e.g., nitrates): combined use can cause severe hypotension. - Anticoagulants (e.g., warfarin): may increase bleeding tendency.

Moderate Interactions (Monitor Closely): - Antiplatelet drugs (e.g., clopidogrel): monitor for enhanced antithrombotic effect. - Antihypertensive agents (e.g., ACE inhibitors): observe blood pressure for additive lowering. - CYP2D6 inhibitors (e.g., fluoxetine): may raise Naftidrofuryl plasma levels.